Comparison of three commonly used fusion tags for the expression of nanobodies in the cytoplasm of Escherichia coli

References

• Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature. 1993;363(6428):446–448.
   PubMed Web of Science ®Google Scholar
• Roux KH, Greenberg AS, Greene L, et al. Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc Natl Acad Sci USA. 1998;95(20):11804–11809.
   PubMed Web of Science ®Google Scholar
• Muyldermans S, Cambillau C, Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem Sci. 2001;26(4):230–235.
   PubMed Web of Science ®Google Scholar
• Muyldermans S. Nanobodies: natural single-domain antibodies. Ann Rev Biochem. 2013;82:775–797.
   PubMed Web of Science ®Google Scholar
• Muyldermans S, Baral TN, Retamozzo VC, et al. Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol. 2009;128(1–3):178–183.
   PubMed Web of Science ®Google Scholar
• Vincke C, Muyldermans S. Introduction to heavy chain antibodies and derived nanobodies. Methods Mol Biol. 2012;911:15–26.
   PubMedGoogle Scholar
• Steyaert J, Kobilka BK. Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol. 2011;21(4):567–572.
   PubMed Web of Science ®Google Scholar
• van der Linden RH, Frenken LG, de Geus B, et al. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta. 1999;1431(1):37–46.
   PubMed Web of Science ®Google Scholar
• Dumoulin M, Conrath K, Van Meirhaeghe A, et al. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002;11(3):500–515.
   PubMed Web of Science ®Google Scholar
• Stijlemans B, Conrath K, Cortez-Retamozo V, et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem. 2004;279(2):1256–1261.
   PubMed Web of Science ®Google Scholar
• Vanlandschoot P, Stortelers C, Beirnaert E, et al. Nanobodies(R): new ammunition to battle viruses. Antiviral Res. 2011;92(3):389–407.
   PubMed Web of Science ®Google Scholar
• Chambers SP, Austen DA, Fulghum JR, et al. High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells. Protein Expr Purif. 2004;36(1):40–47.
   PubMed Web of Science ®Google Scholar
• Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986;189(1):113–130.
   PubMed Web of Science ®Google Scholar
• Ikura K, Kokubu T, Natsuka S, et al. Co-overexpression of folding modulators improves the solubility of the recombinant guinea pig liver transglutaminase expressed in Escherichia coli. Prep Biochem Biotechnol. 2002;32(2):189–205.
   PubMed Web of Science ®Google Scholar
• Marblestone JG, Edavettal SC, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. Protein Sci. 2006;15(1):182–189.
   PubMed Web of Science ®Google Scholar
• Arndt KM, Muller KM, Pluckthun A. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry. 1998;37(37):12918–12926.
   PubMed Web of Science ®Google Scholar
• Worn A, Pluckthun A. Stability engineering of antibody single-chain Fv fragments. J Mol Biol. 2001;305(5):989–1010.
   PubMed Web of Science ®Google Scholar
• Fu X, Gao X, He S, et al. Design and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2). PloS One. 2013;8(3):e56222.
   PubMed Web of Science ®Google Scholar
• Maggi M, Scotti C. Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies. Protein Expr Purif. 2017;136:39–44.
   PubMed Web of Science ®Google Scholar
• Waugh DS. Making the most of affinity tags. Trends Biotechnol. 2005;23(6):316–320.
   PubMed Web of Science ®Google Scholar
• Duplay P, Bedouelle H, Fowler A, et al. Sequences of the malE gene and of its product, the maltose-binding protein of Escherichia coli K12. J Biol Chem. 1984;259(16):10606–10613.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Lee Y, Chang RS, et al. Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1alpha from Escherichia coli. Protein Expr Purif. 2008;60(1):37–45.
   PubMed Web of Science ®Google Scholar
• Guo W, Cao L, Jia Z, et al. High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners. Protein Expr Purif. 2011;77(2):185–192.
   PubMed Web of Science ®Google Scholar
• Hayhurst A. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain. Protein Expr Purif. 2000;18(1):1–10.
   PubMed Web of Science ®Google Scholar
• Bach H, Mazor Y, Shaky S, et al. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J Mol Biol. 2001;312(1):79–93.
   PubMed Web of Science ®Google Scholar
• Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 2007;8(6):550–555.
   PubMed Web of Science ®Google Scholar
• Butt TR, Edavettal SC, Hall JP, et al. SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif. 2005;43(1):1–9.
   PubMed Web of Science ®Google Scholar
• Harmsen MM, De Haard HJ. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol. 2007;77(1):13–22.
   PubMed Web of Science ®Google Scholar
• Noguchi T, Nishida Y, Takizawa K, et al. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli. J Immunol Methods. 2017;442:1–11.
   PubMed Web of Science ®Google Scholar
• Lee CD, Sun HC, Hu SM, et al. An improved SUMO fusion protein system for effective production of native proteins. Protein Sci. 2008;17(7):1241–1248.
   PubMed Web of Science ®Google Scholar
• Mossessova E, Lima CD. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol Cell. 2000;5(5):865–876.
   PubMed Web of Science ®Google Scholar
• Salema V, Fernandez LA. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein. Protein Expr Purif. 2013;91(1):42–48.
   PubMed Web of Science ®Google Scholar